Nemetschek's Two-Speed Story: Record Recurring Revenue Meets a Halved Share Price
Published on 08/01/2026 at 17:36 | Redaktion boerse-global.de
The disconnect between Nemetschek's operational trajectory and its stock market performance has rarely been starker. The Munich-based construction software group closed the acquisition of US firm HCSS on 1 July 2026 — the largest deal in its history — and simultaneously reported that roughly 95 percent of second-quarter revenues now come from recurring sources. Yet the shares remain mired near multi-year lows, down 36.80 percent since the start of the year and 57.47 percent below their 52-week peak of 137.90 euros, hit on 8 August 2025.
Solid headline numbers, one costly exception
On the surface, the Q2 2026 figures tell a story of steady expansion. Revenue climbed 13 percent year-on-year to 327.7 million euros, up from 290.03 million euros in the prior-year period. Net profit advanced 26 percent to 66.04 million euros, with earnings per share rising at the same clip to 0.57 euros. The trailing twelve-month operating margin improved to 19.6 percent from 16.9 percent a year earlier.
The trouble came lower down the income statement. EBITDA missed consensus forecasts due to a one-off charge tied to a revaluation, and the market punished the stock accordingly — at one point the shares fell by roughly 12 percent in the immediate aftermath of the release. The episode underscored how little tolerance investors currently have for any deviation from the elevated expectations built into the company's valuation. Management, for its part, held firm on its full-year guidance, reiterating a target EBITDA margin band of 32 to 33 percent.
The HCSS bet: scale versus integration risk
The strategic logic behind the HCSS acquisition is straightforward. The deal, valued at more than two billion euros and partly financed through a 28 percent stake taken by Thoma Bravo, gives Nemetschek a meaningful foothold in North American infrastructure and heavy civil construction software. With government-led modernisation programmes underpinning that market, supporters argue the timing is opportune.
Bulls point to three supporting pillars: the near-complete transition to a subscription model, which renders cash flows highly predictable; the potential of the new AI suite "Bluebeam Max" to push revenue per user higher; and the valuation cushion built up after such a prolonged share-price decline. The argument runs that much pessimism is already priced in, and if HCSS integration delivers synergies faster than anticipated, a re-rating could follow.
Sceptics counter that the proof of the SaaS and AI promise remains thin. A recurring criticism centres on the absence of a detailed breakdown of recurring revenues — a reporting gap flagged in a recent analyst note as a warning sign. On the balance sheet, the scale of the HCSS deal raises questions about financial headroom, while the broader construction sector's weakness, particularly in Europe, continues to weigh on new business. The second-quarter EBITDA margin of 30.1 percent, below the full-year target corridor, shows the near-term cost of the integration push.
As construction firms focus on operational discipline, workplace safety remains a critical part of the picture. Many employers underestimate how easily risk assessments can fall out of date — leaving them exposed to enforcement action. A free toolkit with 41 ready-to-use templates and checklists helps you document hazards properly and stay compliant. Download the free Risk Assessment Toolkit
Analysts split on fair value
The divergence among sell-side houses is striking. JPMorgan maintains an Overweight rating with a price target of 110 euros, while Jefferies also recommends buying but sees fair value at a far more conservative 70 euros. That gap reflects fundamentally different views on how to weigh the short-term earnings drag from one-off items against the long-term upside from HCSS integration.
Technical picture: support levels and resistance
The chart offers little comfort for the bulls. The stock closed Friday at 58.65 euros, hovering near its 50-day moving average of 58.28 euros. It sits 19.27 percent below the 200-day average of 72.65 euros, a level that would need to be reclaimed to shift the technical bias. The 52-week low of 50.45 euros remains the key downside marker, while the elevated volatility reading of 60.91 percent reflects the market's unsettled mood. Market capitalisation has contracted to 6.69 billion euros over the past year of decline.
What happens next
The third-quarter report will be the first in which HCSS is fully consolidated, making it the natural moment for management to demonstrate that the promised synergies are materialising. If the adjusted EBITDA margin moves back toward 32 percent, the path toward the 200-day line at roughly 70 euros opens up. Until then, the stock remains a test of investor patience — a company growing double digits, expanding into a new segment, and yet trading at a fraction of its former self.
While investors weigh integration risks, companies across the UK are reviewing their compliance obligations more carefully than ever. A free Health & Safety toolkit provides instant access to risk assessments, checklists and toolbox talks covering key regulations like COSHH and PUWER. Over 37,000 UK businesses already use it to protect their teams. Get the free Health & Safety Toolkit
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
